Depression in HIV infected patients: a review (Q35440924)

8 August 2017

1 reference

title

Depression in HIV infected patients: a review (English)

1 reference

8 August 2017

Luigi Grassi

5

0 references

Alex J. Mitchell

object named as

Alex J Mitchell

3

0 references

author name string

Maria Giulia Nanni

1

1 reference

8 August 2017

Rosangela Caruso

2

1 reference

8 August 2017

Elena Meggiolaro

4

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

Current Psychiatry Reports

8 August 2017

1 reference

8 August 2017

17

1 reference

8 August 2017

1

1 reference

8 August 2017

530

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-014-0530-4

8 August 2017

0 references

cites work

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Safety considerations in drug treatment of depression in HIV-positive patients: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Meta-analysis of the relationship between HIV infection and risk for depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Predictive factors and incidence of anxiety and depression in a cohort of HIV-positive patients in French Guiana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

HIV risk behavior among adults with severe mental illness: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Challenges in addressing depression in HIV research: assessment, cultural context, and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Physiological and psychological correlates of fatigue in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

The influence of depression on the progression of HIV: direct and indirect effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Has there been a decrease in the prevalence of mood disorders in HIV-seropositive individuals since the introduction of combination therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Neuropsychiatric complications of aging with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

[Psychosocial aspects on the treatment of HIV-infection].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Underdiagnosis of depression in HIV: who are we missing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Epidemiology of depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Associations between immune depression and cardiovascular events in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

HIV disease progression: depression, stress, and possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Role of depression, stress, and trauma in HIV disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Psychiatric morbidity in asymptomatic human immunodeficiency virus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Incidence and predictive factors of depression among patients with HIV infection in Guadeloupe: 1988-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

HIV and depression--a systematic review of interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Symptoms of depression and anxiety among a sample of South African patients living with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Efficacy of an evidence-based ARV adherence intervention in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Depression and neurocognitive performance in Portuguese patients infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Evaluation of depression and coping skill among HIV-positive people in Kolkata, India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Risk of HIV infection in psychiatrically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Using psychiatric symptomatology to assess risk for HIV infection in individuals with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Association of depression, anxiety, and suicidal ideation with high-risk behaviors among men who inject drugs in Delhi, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Prevalence and clinical course of depression: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Mental health of patients with human immunodeficiency virus in Japan: a comparative analysis of employed and unemployed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

The current status of urban-rural differences in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

The contribution of adult attachment and perceived social support to depressive symptoms in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Determinants of quality of life in HIV-infected patients receiving highly active antiretroviral treatment at a medical college ART center in Kolkata, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

The concept of depression as a dysfunction of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Depression: an inflammatory illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

C-reactive protein and depression in persons with Human Immunodeficiency Virus infection: the Positive Living with HIV (POLH) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Immune activation and inflammation in HIV-1 infection: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Pathophysiology of depression: do we have any solid evidence of interest to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Inflammation-associated depression: from serotonin to kynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Loss and growth: identity processes with distinct and complementary impacts on well-being among those living with chronic illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Illness behavior, emotional stress and psychosocial factors among asymptomatic HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Meta-analysis of health and demographic correlates of stigma towards people living with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Psychosocial correlates of human immunodeficiency virus infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

21 January 2018

Depression and HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Neurocognitive disturbances in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Routine screening for depression: identifying a challenge for successful HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Comparing the accuracy of brief versus long depression screening instruments which have been validated in low and middle income countries: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Validity of the Patient Health Questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Validity of the K-10 in detecting DSM-IV-defined depression and anxiety disorders among HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Treatment of depression in individuals living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Group psychotherapies for depression in persons with HIV: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Psychopharmacology in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Treatment considerations for HIV-infected individuals with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Drug treatment of depression in HIV-positive patients : safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

HIV: effectiveness of complementary and alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

[Review of the effects of mindfulness meditation on mental and physical health and its mechanisms of action].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-014-0530-4

Variations in the probability of depression screening at community-based physician practice visits

21 January 2018

1 reference

12 December 2020

Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS

1 reference

12 December 2020

The neuropathogenesis of HIV-1 infection

1 reference

12 December 2020

Neuropsychiatric manifestations of HIV infection and AIDS

1 reference

12 December 2020

Antiretroviral Therapy (ART) Side Effect Impacted on Quality of Life, and Depressive Symptomatology: A Mixed-Method Study

1 reference

12 December 2020

Depression in HIV-infected patients: allopathic, complementary, and alternative treatments

1 reference

12 December 2020

Inflammatory mechanisms in major depressive disorder

1 reference

12 December 2020

Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence

1 reference

12 December 2020

Assessment on depressive status and the therapeutic effects of highly active antiretroviral therapy among anti-HIV-1(+) population

1 reference

12 December 2020

Depressive Symptoms and Associated Factors among People Living with HIV/AIDS.

1 reference

12 December 2020

Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap

1 reference

12 December 2020

Depressive Symptoms, Neurocognitive Impairment, and Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Persons

1 reference

12 December 2020

Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada.

1 reference

12 December 2020

HIV infection and psychiatric illness

1 reference

12 December 2020

Depressive and anxiety disorders in women with HIV infection

1 reference

12 December 2020

Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies

1 reference

12 December 2020

Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon

1 reference

12 December 2020

[Depression in HIV infection: prevalence, risk factors and management]

1 reference

12 December 2020

Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances

1 reference

12 December 2020

Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy

1 reference

12 December 2020

Major depression-related immunological changes and combination antiretroviral therapy in HIV-seropositive patients

1 reference

12 December 2020

Analysis of neuropsychiatric adverse events during clinical trials of efavirenz in antiretroviral-naive patients: a systematic review.

1 reference

12 December 2020

10.1007/S11920-014-0530-4

Identifiers

DOI

1 reference

8 August 2017

1 reference